CoChat

Resistin Is a Key Mediator of Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Lipoprotein Lipase (LPL) Activity in Adipocytes

Open access
Kim, Su-Jin, Nian, Cuilan, McIntosh, Christopher H.S. · 2007 · Journal of Biological Chemistry

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Studies on the physiological roles of the incretin hormone, glucose-dependent insulinotropic polypeptide (GIP) have largely focused on its insulinotropic action and ability to regulate beta-cell mass. In previous studies on the stimulatory effect of GIP on adipocyte lipoprotein lipase (LPL), a pathway was identified involving increased phosphorylation of protein kinase B (PKB) and reduced phosphorylation of LKB1 and AMP-activated protein kinase (AMPK). The slow time of onset of the responses suggested that GIP may have induced release of an intermediary molecule, and the current studies focused on the possible contribution of the adipokine resistin. In differentiated 3T3-L1 adipocytes, GIP, in the presence of insulin, increased resistin secretion through a pathway involving p38 mitogen-activated protein kinase (p38 MAPK) and the stress-activated protein kinase/Jun amino-terminal kinase (SAPK/JNK). The other major incretin hormone, glucagon-like peptide-1 (GLP-1), exhibited no significant effects. Chronic elevation of circulating GIP levels in the Vancouver Diabetic Fatty (VDF) Zucker rat resulted in increases in circulating resistin levels and activation of p38 MAPK or SAPK/JNK in epididymal fat tissue, suggesting the existence of identical pathways in vivo as well as in vitro. Administration of resistin to 3T3-L1 adipocytes mimicked the effects of GIP on the PKB/LKB1/AMPK/LPL pathway: increasing phosphorylation of PKB, reducing levels of phosphorylated LKB1 and AMPK, and increasing LPL activity. Knockdown of resistin using RNA interference attenuated the effect of GIP on the PKB/LKB1/AMPK/LPL pathway in 3T3-L1 adipocytes, supporting a role for resistin as a mediator.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m704896200

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 The effect of GIP and GLP-1 on the secretion of resistin. A , time course of GIP and GLP-1 action on resistin secretion. Differentiated 3T3-L1 adipocytes were serum starved in 3 mM glucose/DMEM containing 0.1% bovine serum albumin overnight and INS-1 (832/13) cells were serum starved in 3 mM glucose/RPMI containing 0.1% bovine serum albumin overnight. 3T3-L1 adipocytes and INS-1 cells were treated for the indicated periods of time with GIP or GLP-1 (100 nM) in the presence of insulin (1 nM). B , concentration dependence of GIP and GLP-1 effects on resistin secretion. 3T3-L1 adipocytes and INS-1 (832/13) cells were treated for 2 h with the indicated concentrations of GIP or GLP-1 in the presence of insulin (1 nM). Resistin levels in culture media were determined using resistin ELISA kit. C , the effect of GIP and GLP-1 on resistin mRNA expression. 3T3-L1 adipocytes were treated as described above and incubated with GIP or GLP-1 (100 nM) for 6 h in the presence of insulin (1 nM). Total RNA was isolated from each sample and real-time reverse transcriptase-PCR was performed to quantify resistin mRNA ( Retn ) levels; shown as the -fold difference versus control normalized to 𝛃 -actin expression levels. All data represent three independent experiments, each carried out in duplicate. Significance was tested using ANOVA with NewmanKeuls post hoc test, where ** represents p < 0.05 versus control.
FIGURE 1 The effect of GIP and GLP-1 on the secretion of resistin. A , time course of GIP and GLP-1 action on resistin secretion. Differentiated 3T3-L1 adipocytes were serum starved in 3 mM glucose/DMEM containing 0.1% bovine serum albumin overnight and INS-1 (832/13) cells were serum starved in 3 mM glucose/RPMI containing 0.1% bovine serum albumin overnight. 3T3-L1 adipocytes and INS-1 cells were treated for the indicated periods of time with GIP or GLP-1 (100 nM) in the presence of insulin (1 nM). B , concentration dependence of GIP and GLP-1 effects on resistin secretion. 3T3-L1 adipocytes and INS-1 (832/13) cells were treated for 2 h with the indicated concentrations of GIP or GLP-1 in the presence of insulin (1 nM). Resistin levels in culture media were determined using resistin ELISA kit. C , the effect of GIP and GLP-1 on resistin mRNA expression. 3T3-L1 adipocytes were treated as described above and incubated with GIP or GLP-1 (100 nM) for 6 h in the presence of insulin (1 nM). Total RNA was isolated from each sample and real-time reverse transcriptase-PCR was performed to quantify resistin mRNA ( Retn ) levels; shown as the -fold difference versus control normalized to 𝛃 -actin expression levels. All data represent three independent experiments, each carried out in duplicate. Significance was tested using ANOVA with NewmanKeuls post hoc test, where ** represents p < 0.05 versus control.CC-BY · From the PDF
Image 2
CC-BY · From the PDF
FIGURE3 p38MAPKandSAPK/JNKareinvolvedinGIP-mediatedresistin secretion. A , effect of inhibiting p38 MAPK or SAPK/JNK on resistin secretion. Differentiated 3T3-L1 adipocytes were serum starved in 3 mM glucose/DMEM containing 0.1% bovine serum albumin overnight and stimulated for 2 h with 100 nM GIP in the presence or absence of inhibitors of MAPK pathways. PD98059 (75 𝛍 M), U0126 (25 𝛍 M), SB203580 (10 𝛍 M), and SP600125 (50 𝛍 M) were added to cells during 1 h preincubation as well as during GIP stimulation. Resistin levels in the culture media were determined using a resistin ELISA. B , effect of p38 MAPK or SAPK/JNK inhibition on resistin protein levels. 3T3-L1 adipocytes were treated as described above, total cellular extracts were isolated from each sample and resistin was determined by Western blotting. All data represent three independent experiments, each carried out in duplicate and Western blots are representative of n = 3. Significance was tested using ANOVA with Newman-Keuls post hoc test, where ** represents p < 0.05 versus control; ## represents p < 0.05 versus control + GIP.
FIGURE3 p38MAPKandSAPK/JNKareinvolvedinGIP-mediatedresistin secretion. A , effect of inhibiting p38 MAPK or SAPK/JNK on resistin secretion. Differentiated 3T3-L1 adipocytes were serum starved in 3 mM glucose/DMEM containing 0.1% bovine serum albumin overnight and stimulated for 2 h with 100 nM GIP in the presence or absence of inhibitors of MAPK pathways. PD98059 (75 𝛍 M), U0126 (25 𝛍 M), SB203580 (10 𝛍 M), and SP600125 (50 𝛍 M) were added to cells during 1 h preincubation as well as during GIP stimulation. Resistin levels in the culture media were determined using a resistin ELISA. B , effect of p38 MAPK or SAPK/JNK inhibition on resistin protein levels. 3T3-L1 adipocytes were treated as described above, total cellular extracts were isolated from each sample and resistin was determined by Western blotting. All data represent three independent experiments, each carried out in duplicate and Western blots are representative of n = 3. Significance was tested using ANOVA with Newman-Keuls post hoc test, where ** represents p < 0.05 versus control; ## represents p < 0.05 versus control + GIP.CC-BY · From the PDF
FIGURE 4 Effect of GIP on resistin levels in vivo . VDFrats and their lean littermate controls received a 2-week continuous infusion of GIP (10 pmol/kg/min) or phosphate-buffered saline vehicle. A , resistin expression in epididymal fat tissue. Immunohistochemical staining was performed using resistin antibody and imaging performed using a Zeiss laser scanning confocal microscope (Axioskop2). B , the effect of GIP infusion on circulating plasma resistin levels. Following a 2-week GIP infusion, plasma samples were taken from each group of animals, and plasma resistin levels determined as described under 'Experimental Procedures.' C , the effect of GIP infusion on resistin expression in epididymal fat tissue. Total cellular extracts were prepared from epididymal fat tissues and Western blot analyses performed using antibodies against resistin and 𝛃 -actin. D and E , the effect of GIP on kinase phosphorylation. Western blot analyses were performed using antibodies against p38 MAPK (Thr 180 /Tyr 182 ) ( D ), SAPK/JNK (Thr 183 /Tyr 185 ) ( E ), and 𝛃 -actin. All imaging data were analyzed using the Northern Eclipse program (version 6) and the scale bar indicates 50 𝛍 m. Data represent three independentexperiments, each carried out in duplicate and Western blots are representative of n = 3. Significance was tested using ANOVA with Newman-Keuls post hoc test, where ** represents p < 0.05 versus lean; ## represents p < 0.05 versus fatty.
FIGURE 4 Effect of GIP on resistin levels in vivo . VDFrats and their lean littermate controls received a 2-week continuous infusion of GIP (10 pmol/kg/min) or phosphate-buffered saline vehicle. A , resistin expression in epididymal fat tissue. Immunohistochemical staining was performed using resistin antibody and imaging performed using a Zeiss laser scanning confocal microscope (Axioskop2). B , the effect of GIP infusion on circulating plasma resistin levels. Following a 2-week GIP infusion, plasma samples were taken from each group of animals, and plasma resistin levels determined as described under 'Experimental Procedures.' C , the effect of GIP infusion on resistin expression in epididymal fat tissue. Total cellular extracts were prepared from epididymal fat tissues and Western blot analyses performed using antibodies against resistin and 𝛃 -actin. D and E , the effect of GIP on kinase phosphorylation. Western blot analyses were performed using antibodies against p38 MAPK (Thr 180 /Tyr 182 ) ( D ), SAPK/JNK (Thr 183 /Tyr 185 ) ( E ), and 𝛃 -actin. All imaging data were analyzed using the Northern Eclipse program (version 6) and the scale bar indicates 50 𝛍 m. Data represent three independentexperiments, each carried out in duplicate and Western blots are representative of n = 3. Significance was tested using ANOVA with Newman-Keuls post hoc test, where ** represents p < 0.05 versus lean; ## represents p < 0.05 versus fatty.CC-BY · From the PDF
FIGURE 5 Effect of resistin on phosphorylation of PKB, LKB1 and AMPK, and LPL activity. Time course of phosphorylation of PKB ( A ), LKB1 ( B ), and AMPK ( C ) in the presence of resistin. 3T3-L1 adipocytes were serum starved in 3 mM glucose/DMEM containing 0.1% bovine serum albumin overnight and stimulated for the indicated periods of time with resistin (10 nM). Total cellular extracts were isolated and Western blot analyses performed with antibodies against phosphorylated Thr 172 -AMPK, AMPK, Ser 428 -LKB1, Ser 473 -PKB or PKB, and 𝛃 -actin. Time course ( D ) and concentration-response effect ( E ) of resistin on LPL activity. 3T3-L1 adipocytes were treated for the indicated periods of time with resistin (10 nM) ( A-D ) or for 24 h with the indicated concentrations of resistin ( E ). Western blots are representative of n = 3 and significance was tested using ANOVA with Newman-Keuls post hoc test, where * represents p < 0.05 versus basal.
FIGURE 5 Effect of resistin on phosphorylation of PKB, LKB1 and AMPK, and LPL activity. Time course of phosphorylation of PKB ( A ), LKB1 ( B ), and AMPK ( C ) in the presence of resistin. 3T3-L1 adipocytes were serum starved in 3 mM glucose/DMEM containing 0.1% bovine serum albumin overnight and stimulated for the indicated periods of time with resistin (10 nM). Total cellular extracts were isolated and Western blot analyses performed with antibodies against phosphorylated Thr 172 -AMPK, AMPK, Ser 428 -LKB1, Ser 473 -PKB or PKB, and 𝛃 -actin. Time course ( D ) and concentration-response effect ( E ) of resistin on LPL activity. 3T3-L1 adipocytes were treated for the indicated periods of time with resistin (10 nM) ( A-D ) or for 24 h with the indicated concentrations of resistin ( E ). Western blots are representative of n = 3 and significance was tested using ANOVA with Newman-Keuls post hoc test, where * represents p < 0.05 versus basal.CC-BY · From the PDF
Image 6
CC-BY · From the PDF
FIGURE7 ProposedpathwaybywhichGIPincreasesresistinsecretionandLPLactivityinadipocytes. GIP receptor interaction results in activation of p38 MAPK and SAPK/JNK, leading to the secretion of resistin. Secretedresistin acts in either an autocrine or paracrine manner to increase PKB phosphorylation and decrease LKB1 and AMPK phosphorylation, resulting in increased LPL activity. There is the potential for involvement of other growth factors/hormones in the regulatory pathway.
FIGURE7 ProposedpathwaybywhichGIPincreasesresistinsecretionandLPLactivityinadipocytes. GIP receptor interaction results in activation of p38 MAPK and SAPK/JNK, leading to the secretion of resistin. Secretedresistin acts in either an autocrine or paracrine manner to increase PKB phosphorylation and decrease LKB1 and AMPK phosphorylation, resulting in increased LPL activity. There is the potential for involvement of other growth factors/hormones in the regulatory pathway.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 4

  1. Pederson, R. A., and McIntosh, C. H. S. (2004) in Encyclopedia of Endo- crine Diseases, (Martini, L., ed) Vol. 2, pp. 202-207, Elsevier Inc., New York
  2. Brown, J. C., Buchan, A. M., McIntosh, C. H. S., and Pederson, R. A. (1989) in Handbook of Physiology (Schultz, S. G., Makhlouf, G. M., and Rauner, B. B., eds) pp. 403-430, American Physiology Society, Bethesda, MD 17.
  3. Skurk, T., Alberti-Huber, C., Herder, C., and Hauner, H. (2007) Endocri- nology 92, 1023-1033
  4. Roh, C., Thoidis, G., Farmer, S. R., and Kandror, K. V. (2000) Am. J. Physiol. 279, E893-E899

Cited by

Metadata

Authors
Kim, S.-J., Nian, C., & McIntosh, C. H. S.
Affiliations
University of British Columbia (CA)
Corresponding author
McIntosh, Christopher H.S.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2007-11
Volume
282
Issue
47
Pages
34139-34147
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2057235055
Cited by
118
References
55
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 1 · 2019: 4 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 8 · 2012: 12
FWCI
7.34
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
resistin, glucose-dependent insulinotropic polypeptide, lipoprotein lipase, adipocytes, p38 MAPK, SAPK/JNK, Akt, LKB1, AMPK, incretins, glucagon-like peptide-1, 3T3-L1 adipocytes, adipokines, insulin signaling, epididymal adipose tissue
MeSH terms
AMP-Activated Protein Kinase Kinases, Animals, Enzyme Activation, Epididymis, Gastric Inhibitory Polypeptide, Insulin, Lipoprotein Lipase, Male, Multienzyme Complexes, Rats, Zucker, Second Messenger Systems, 3T3 Cells, Protein Serine-Threonine Kinases, Adipocytes, MAP Kinase Signaling System, RNA Interference, p38 Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Insulin-Secreting Cells, Proto-Oncogene Proteins c-akt, Mice, Rats, Glucagon-Like Peptide 1, Resistin, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.